Professor Deirdre Lane PhD, FRCPE, FHEA, FESC, BSc

Professor Deirdre Lane

Institute of Applied Health Research
Honorary Professor of Cardiovascular Health

Contact details

University of Birmingham
B15 2TT

Professor Deirdre Lane is an Honorary Professor of Cardiovascular Health at the University of Birmingham and an Adjunct Professor of Cardiovascular Health at Aalborg University, Denmark.

Her background is in health psychology and cardiovascular epidemiology and her research examines how cardiovascular disease affects patients’ quality of life and psychological well-being, their perceptions of the condition(s) and treatment, and how patient education impacts treatment adherence, using quantitative and qualitative methodology. Her main research interest is atrial fibrillation, with two major themes: patient-centred research and stroke and bleeding risk stratification and stroke prevention. Together with clinical colleagues, Professor Lane has been integral in refining the risk stratification of atrial fibrillation patients requiring oral anticoagulant therapy based on their bleeding and stroke risk, deriving and validating stroke (CHA2DS2-VASc) and bleeding (HAS-BLED) risk schemas, which are widely used both nationally and internationally in clinical practice. This has had a significant impact on patient care globally. Professor Lane is also involved in clinical trials and international registry studies related to atrial fibrillation. Her programme of research is focussed on stroke prevention and improving the management of atrial fibrillation through the promotion and implementation of guideline-adherent clinical practice and patient and physician education, in collaboration with hospital Trusts, primary care, patients, patient organisations and industry, both nationally and internationally. Professor Lane is currently rated as one of the top 10 world experts in atrial fibrillation by Expertscape and she is regularly invited to speak at national and international conferences on atrial fibrillation.


  • Fellow of the European Society of Cardiology 2015
  • Postgraduate Certificate in Academic Practice, University of Birmingham 2013
  • Fellow of the Royal College of Physicians Edinburgh 2012
  • Fellow of the Higher Education Academy 2012
  • PhD, University of Birmingham 2000
  • BSc (Hons) Psychology, University of Liverpool 1995


Professor Deirdre Lane is currently Reader in Cardiovascular Health at the University of Liverpool, Honorary Professor at the University of Birmingham and Adjunct Professor of Cardiovascular Health at Aalborg University, Denmark.

Her main research interest is atrial fibrillation (AF), with two major themes: patient-centred research and stroke and bleeding risk stratification and stroke prevention.  In collaboration, she has developed and validated stroke and bleeding risk clinical prediction tools, the CHA2DS2-VASc score and HAS-BLED score, respectively, which are internationally recognised as being innovative and have been incorporated into most major international guidelines (e.g., NICE, European Society of Cardiology, Canadian College of Cardiology, Asia Pacific Heart Rhythm Society) on the management of AF. This has had a significant impact on clinical practice. The validation of these risk schemas in AF cohorts has also led to several national and international collaborations and high-quality peer-reviewed publications in prominent journals. The importance of this research on clinical practice has also been acknowledged by a number of prestigious awards and as an Impact Case in the Research Excellence Framework (REF) 2014 ( This work is currently being extended beyond risk stratification to implementation of guideline-adherent AF management and integrated AF care utilising the ABC (Atrial Fibrillation Better Care) pathway.


  • Atrial fibrillation: stroke and bleeding risk
  • Patient-centred care in cardiovascular disease
  • Global Atrial Fibrillation Care- international collaborations to improve atrial fibrillation care for patients

Research groups and centres

Other activities

  • Thrombosis and Haemostasis (Section Editor, 2018 - 2021)
  • Heart (International Advisory Board, 2016 – 2019, 2020-2024)
  • Advisory Committee on Clinical Excellence Awards (ACCEA) (2018 - 2022)
  • European Heart Rhythm Association (EHRA) Scientific Initiatives Committee (2017 - 2020)
  • International Consortium for Health Outcomes Measurement (ICHOM) Atrial Fibrillation Working Group (2018 - 2019)
  • American College of Chest Physicians Guideline Committee on Antithrombotic therapy in atrial fibrillation patients (2016 - 2018)
  • European Heart Rhythm Association (EHRA) Scientific Documents Writing Committee (2013 - 2017)


  • Google Scholar H-index: 77
  • >240 peer-reviewed publications

Selected publications 2015-2020

  • SeligmanWH, Das-GuptaZ, Jobi-OdeneyeAO, ArbeloE BanerjeeA, BollmannA, Caffrey-Armstrong B, Cehic DA, Corbalan R, Collins M, Dandamudi G, Dorairaj P, Fay M,  van Gelder IC, Goto S, Granger C, Gyorgy B, Healey JS, Hendriks JM, True Hills M, Hobbs FDR, Huisman MV, Koplan KE, Lane DA, Lewis WR, Lobban T, Steinberg BA, McLeod CJ, Moseley Timmis A, Yutao G, Camm AJ. Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) AF WG. Eur Heart J 2020; in press.
  • Guo Y, Lane DA, Wang L, Chen Y, Lip GYH, on behalf of the mAF-App II Trial investigators. Mobile Health (mHealth) technology for improved screening, patient involvement and optimizing integrated care in atrial fibrillation: The mAFA (mAF-App) II randomized trial. Int J Clin Pract 2019; 73: e13352
  • Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane  DA, Ruff C, Turakhia M, Werring D, Patel S, Moores L. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest 2018; Aug 21. pii: S0012-3692(18)32244-X. doi: 10.1016/j.chest.2018.07.040.
  • Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway. Am J Med 2018;,ed.2018.06.012
  • Reavell J, Hopkinson M, Clarkesmith DE, Lane DA. Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosom Med 2018; 8: 742-753.
  • Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence and mortality of atrial fibrillation in primary care. JAHA 2017; Apr 28; 6(5). pii: e005155. doi:10.1161/JAHA.116.005155
  • Guo Y, Chen Y C, Lane DA, Liu L, Wang Y, Lip GYH. Mobile health (mHealth) technology integrating clinical decision support and patient involvement for the management of patients with atrial fibrillation: The mAFA (mAF-App) randomized trial. Am J Cardiol 2017; 130(12):1388-1396.  doi: 10.1016/j.amjmed.2017.07.003.
  • Clarkesmith DE, Pattison HM, Khaing PH, Lane DA. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev. 2017, Issue 4. Art. No.: CD008600. doi:10.1002/14651858.CD008600.pub3.
  • Kotecha D, Ahmad A, Calvert M, Lencioni M, Terwee CB, Lane DA. Patient-reported outcomes for quality of life assessment in atrial fibrillation: A systematic review of measurement properties. PLoS ONE 2016; 11(11): e0165790.  doi:10.1371/journal.pone.0165790.
  • Borg Xuereb C, Shaw RL, Lane DA. Patients’ and physicians’ experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design. Psychol Health 2016; 31: 436-455
  • Lane DA, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan GA, Hills MT, Hylek EM, LaHaye SA, Lip GY, Lobban T, Mandrola J, McCabe PJ, Pedersen SS, Pisters R, Stewart S, Wood K, Potpara TS; Document Reviewers:, Gorenek B, Conti JB, Keegan R, Power S, Hendriks J, Ritter P, Calkins H, Violi F, Hurwitz J. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).Europace. 2015; 17(12): 1747-1769. doi: 10.1093/europace/euv233
  • Lane DA, Wood K. A patient’s guide to the NOACs. Circulation 2015; 131; e412-e415
  • Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation.JAMA. 2015; 314(10):1030-8. doi: 10.1001/jama.2015.10725
  • Gorst-Rasmussen A, Skjøth F, Larsen TB, Rasmussen LH, Lip GYH,Lane DA. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. J Thromb Haemost2015; 13: 495-504. doi:10.1111/jth.12845

View all publications in research portal


Professor Deirdre Lane is an Honorary Professor in Cardiovascular Health. Her research is primarily concerned with stroke and bleeding risk in atrial fibrillation, and in patient’s perceptions and understanding of the disease and its treatment.